GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAY) » Definitions » 3-Year RORE %

Elekta AB (Elekta AB) 3-Year RORE % : 14.61% (As of Jan. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Elekta AB 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Elekta AB's 3-Year RORE % for the quarter that ended in Jan. 2024 was 14.61%.

The industry rank for Elekta AB's 3-Year RORE % or its related term are showing as below:

EKTAY's 3-Year RORE % is ranked better than
84.32% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: -4.57 vs EKTAY: 14.61

Elekta AB 3-Year RORE % Historical Data

The historical data trend for Elekta AB's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB 3-Year RORE % Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.17 -22.62 7.58 11.14 -50.88

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.59 -50.88 -26.88 -10.70 14.61

Competitive Comparison of Elekta AB's 3-Year RORE %

For the Medical Instruments & Supplies subindustry, Elekta AB's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB's 3-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Elekta AB's 3-Year RORE % falls into.



Elekta AB 3-Year RORE % Calculation

Elekta AB's 3-Year RORE % for the quarter that ended in Jan. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.356-0.324 )/( 0.892-0.673 )
=0.032/0.219
=14.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jan. 2024 and 3-year before.


Elekta AB  (OTCPK:EKTAY) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Elekta AB 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Elekta AB's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB (Elekta AB) Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.

Elekta AB (Elekta AB) Headlines